Presentations and films

Celon Pharma Announces Positive Falkieri Phase II Results in Treatment-Resistant Bipolar Depression

Shareholders of Celon Pharma S.A. On February 16, 2021, they will decide to authorize the Management Board to increase the share capital within the authorized capital by issuing new shares.